drugset
drugset / Trial / NCT03386201

FLuorescence Cholangiography Using Methylene Blue

NCT03386201 ↗

Unknown 40 enrolled University of Oxford Oxford University Hospitals NHS Trust · collab
NaSingle-groupOpen-labelOther

Summary

Open label prospective, non-randomised proof of principle study assessing the use of methylene blue fluorescence cholangiography.

Timeline

Start
2018-01-01
Primary completion
2018-06-01
Completion
2018-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylene Blue Diagnostic / imaging agent — Intravenous

Indications

bile duct disorder